INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - NYSE:INSP - US4577301090 - Common Stock
83.57 USD
-1.3 (-1.53%)
83.57 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to INSP. INSP was compared to 188 industry peers in the Health Care Equipment & Supplies industry. INSP has an excellent financial health rating, but there are some minor concerns on its profitability. INSP is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, INSP could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
INSP had a positive operating cash flow in the past year.
INSP had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
INSP has a better Return On Assets (5.52%) than 82.45% of its industry peers.
The Return On Equity of INSP (6.69%) is better than 79.79% of its industry peers.
With a decent Return On Invested Capital value of 4.82%, INSP is doing good in the industry, outperforming 76.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of INSP (5.05%) is better than 76.06% of its industry peers.
With a decent Operating Margin value of 4.16%, INSP is doing good in the industry, outperforming 68.62% of the companies in the same industry.
The Gross Margin of INSP (84.92%) is better than 94.68% of its industry peers.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for INSP has been increased compared to 1 year ago.
The number of shares outstanding for INSP has been increased compared to 5 years ago.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
INSP has an Altman-Z score of 12.12. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
INSP's Altman-Z score of 12.12 is amongst the best of the industry. INSP outperforms 90.96% of its industry peers.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.12 |
ROIC/WACC0.55
WACC8.77%
2.3 Liquidity
A Current Ratio of 5.29 indicates that INSP has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.29, INSP belongs to the top of the industry, outperforming 81.91% of the companies in the same industry.
A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
INSP has a better Quick ratio (4.01) than 77.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.65%, which is quite impressive.
INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.81%.
INSP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.78% yearly.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
INSP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.29% yearly.
INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.84% yearly.
EPS Next Y-70.2%
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
EPS Next 5Y28.29%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y13.96%
Revenue Next 5Y12.84%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 40.97, which means the current valuation is very expensive for INSP.
INSP's Price/Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 69.68% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.56. INSP is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 51.87, which means the current valuation is very expensive for INSP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 68.62% of the companies listed in the same industry.
INSP's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 34.62.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.97 | ||
| Fwd PE | 51.87 |
4.2 Price Multiples
67.55% of the companies in the same industry are more expensive than INSP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, INSP is valued cheaply inside the industry as 80.32% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.01 | ||
| EV/EBITDA | 40.07 |
4.3 Compensation for Growth
A more expensive valuation may be justified as INSP's earnings are expected to grow with 16.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
5. Dividend
5.1 Amount
No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
83.57
-1.3 (-1.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.56%
Inst Owner Change-6.75%
Ins Owners0.82%
Ins Owner Change4.2%
Market Cap2.47B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts73.85
Price Target127.13 (52.12%)
Short Float %12.31%
Short Ratio2.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-9.02%
PT rev (3m)-28.54%
EPS NQ rev (1m)0.73%
EPS NQ rev (3m)-36.55%
EPS NY rev (1m)2.8%
EPS NY rev (3m)-77.7%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)-1.16%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-4.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.97 | ||
| Fwd PE | 51.87 | ||
| P/S | 2.8 | ||
| P/FCF | 25.01 | ||
| P/OCF | 18.48 | ||
| P/B | 3.71 | ||
| P/tB | 3.71 | ||
| EV/EBITDA | 40.07 |
EPS(TTM)2.04
EY2.44%
EPS(NY)1.61
Fwd EY1.93%
FCF(TTM)3.34
FCFY4%
OCF(TTM)4.52
OCFY5.41%
SpS29.85
BVpS22.54
TBVpS22.54
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 12.12 |
F-Score8
WACC8.77%
ROIC/WACC0.55
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-70.2%
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
EPS Next 5Y28.29%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y13.96%
Revenue Next 5Y12.84%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year586.15%
EBIT Next 3Y128.27%
EBIT Next 5Y79.93%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
Can you provide the ChartMill fundamental rating for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
What is the valuation status of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
Can you provide the profitability details for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
Can you provide the financial health for INSP stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.
What is the expected EPS growth for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -70.2% in the next year.